Reaction
Urticaria Thermal reporting signals
As of the last recalculation, Urticaria Thermal appears in 142 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is OMALIZUMAB (PRR 507.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Omalizumab | 96 | 507.6 | 508.2 |
| Niacin | 20 | 293.6 | 294.1 |
| Cetirizine Hydrochloride Allergy | 34 | 216.1 | 216.3 |
| Cetirizine Hydrochloride Tablets | 34 | 216.0 | 216.3 |
| Doxepin | 12 | 189.5 | 189.7 |
| Hydroxyzine | 42 | 182.9 | 183.1 |
| Doxepin Hydrochloride | 12 | 152.1 | 152.2 |
| Desoximetasone | 13 | 110.0 | 110.1 |